Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.

<h4>Unlabelled</h4>None of the available osteoporosis therapies have been shown to completely abolish the risk of fractures. In clinical practice, the outcome may be even poorer. In 880 patients prescribed with antiresorptives (alendronate, risedronate, and raloxifene) for >1 year, a fragility fract... View More